Dan Braga is the Vice President, Product Management for medical imaging solutions at Medidata Solutions. Dan works with sponsors, CROs, core labs, and sites to adopt medical image technologies to help automate image acquisition, distribution, assessment, and data collection.

Prior to Medidata, Dan was one of the co-founders of Intelemage, a medical image management and workflow company later acquired by Medidata. Prior to Intelemage, Dan worked in various product management, operational and sales roles with healthcare technology companies such as GE Healthcare, PocketScript, and WebMD.

Troy Schneider is the Vice President of Connected Data responsible for the strategy and business development of growing one of the world’s most sophisticated networks dedicated to providing secure, powerful and intelligent management and workflows of medical images for the life sciences industry.

Bryant has enjoyed nearly 25 years in clinical research domain, mostly comprised of industry leadership in clinical data management and clinical operations. Most notably, he developed and led a global team of clinical data managers in the successful delivery of high quality data in Oncology, Hemophilia and Ophthalmology submissions. Bryant has led workstreams in the identification of innovative and transformative process and tools for future clinical data environments. Immediately prior to joining Medidata, he supported departments in clinical data standards and HEOR research. Bryant is currently the Director, Data Science and Analytics Portfolio where he ensures seamless coordination and oversight between commercialization, marketing, strategy and corporate development operations for Data Science products and solutions.

Elizabeth Lamont is Senior Medical Director at Medidata AI, Medidata Solutions, a Dassault Systèmes company which powers smarter treatments and healthier people. 

A physician scientist, Elizabeth supports Medidata AI product development team as a subject matter expert in health outcomes research methodologies for real-world and clinical trial data and in clinical medicine. She supports Medidata AI work across multiple product areas including synthetic controls, intelligent trials, trial design, and medical analytics and outcomes research. Further, she has led efforts to estimate the impact of the COVID-19 pandemic on oncology clinical research and development through collaborative studies of data from Medidata Enterprise Data Solutions. The resultant products ultimately drive value for Medidata’s customers and positive outcomes for patients.

A medical oncologist, Elizabeth had a >25 year career in academic medicine, first at the University of Chicago and then at Harvard Medical School and Massachusetts General Hospital. She is internationally recognized as an innovative health outcomes researcher with a history of continuous federal grant funding and >100 scientific publications. In 2015 she founded Salient Care, LLC, a patient-centric health information technology company, through which she developed the patient app “My Health Team” and inpatient product “Tele-Rounds”. She was Senior Medical Director for Research at COTA prior to joining Medidata in 2020.

Elizabeth received her M.D. from the Geisel School of Medicine at Dartmouth, an M.S. in health studies from the University of Chicago, and an M.M.Sc. in biomedical informatics from Harvard Medical School. She completed her Internal Medicine residency at the Brigham and Women’s Hospital and her Hematology-Oncology fellowship at the University of Chicago where she was also a Robert Wood Johnson Clinical Scholar.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,600+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.

Caleb Strait is a Senior Data Scientist with Medidata AI’s Trial Design team, focusing on adverse event prediction in T-cell-based immunotherapies. He has over 11 years of experience in the medical event prediction space, and holds a PhD in computational neuroscience, with first-author publications in numerous high-impact journals, including Neuron, and PLoS Biolo

Vibhu Agarwal leads the development of algorithms and analytics pipelines to support immunotherapeutic development in oncology (CAR-T, TCR, ImmTAC). Recent work focuses on safety profiling and predicting CRS and ICANS episodes in interventional trials. More broadly includes sequence modeling techniques for noisy, multivariate SDTM/ADaM data.

With over two decades of experience in quantitative analysis, earlier work has focused on modeling biomedical data to recapitulate relationships between health outcomes and patient care data from EHRs, claims, clinical trials, wearable sensors and web search logs. A former national awardee, he successfully sold his first venture in computational linguistics to Nuance Communication, a global leader in speech and language technology. He holds a PhD in Biomedical Informatics and Statistics (minor) from Stanford University, a MBA from Hitotsubashi University (Tokyo, Japan) and a B. Tech from the Indian Institute of Technology (Kanpur, India).

Vibhu currently serves as the Senior Director, Data Science (Trial Design Solutions) at Medidata AI.

Andrea Falkoff is Director of Product Management, responsible for the Medidata Adjudicate and Rave Imaging product roadmaps. Andrea also works directly with customers and internal stakeholders to ensure best practices are applied across imaging and endpoint adjudication trial builds.

Andrea joined Medidata from WorldCare Clinical, where she led the operations team, ensuring quality delivery of Imaging and Endpoint Adjudication trials for pharmaceutical, biotech and medical device companies. She has more than 14 years of experience working for various imaging/endpoint adjudication core labs and a proven track record for customer satisfaction and quality delivery.